首页 | 本学科首页   官方微博 | 高级检索  
     


Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic
Authors:M.W. Ho  E.A. Field  J.K. Field  J.M. Risk  B.P. Rajlawat  S.N. Rogers  J.C. Steele  A. Triantafyllou  J.A. Woolgar  D. Lowe  R.J. Shaw
Affiliation:1. Regional Maxillofacial Unit, Aintree University Hospital, Liverpool, UK;2. Molecular and Clinical Cancer Medicine, School of Cancer Studies, University of Liverpool, UK;3. Department of Oral Pathology, Aintree University Hospitals, NHS Foundation Trust, UK;4. Department of Oral Medicine, Liverpool University Dental Hospital, UK;5. Evidence-Based Practice Research Centre (EPRC), Faculty of Health, Edge Hill University, Ormskirk, UK
Abstract:Surveillance of oral epithelial dysplasia results in a number of newly diagnosed cases of oral squamous cell carcinoma (SCC). The clinical stage of oral SCC at diagnosis influences the magnitude of treatment required and the prognosis. We aimed to document the stage, treatment, and outcome of oral SCC that arose in patients who were being monitored for oral epithelial dysplasia in a dedicated multidisciplinary clinic. Those with histologically diagnosed lesions were enrolled on an ethically approved protocol and molecular biomarker study. Details of clinical and pathological TNM, operation, radiotherapy, recurrence, second primary tumour, and prognosis, were recorded in patients whose lesions underwent malignant transformation. Of the 91 patients reviewed (median follow-up 48 months, IQR 18-96), 23 (25%) had malignant transformation. All were presented to the multidisciplinary team with stage 1 disease (cT1N0M0). Of these, 21 were initially treated by wide local excision, 2 required resection of tumour and reconstruction, and 2 required adjuvant radiotherapy. At follow-up 3 had local recurrence, one had regional recurrence, one had metachronous lung cancer, and 5 had second primary oral SCC. There were further diagnoses of oral dysplasia in 5 during follow-up, and it is estimated that 76% of patients will have one or other event in 5 years. Disease-specific survival was 100% and overall survival was 96% (22/23). Median follow-up after diagnosis of oral SCC was 24 months (IQR 11-58). Specialist monitoring of oral epithelial dysplasia by a multidisciplinary team allows oral SCC to be detected at an early stage, and enables largely curative treatment with simple and usually minor surgical intervention. The high incidence of second primary oral SCC in high-risk patients with oral epithelial dysplasia further supports intensive targeted surveillance in this group.
Keywords:Oral dysplasia   Oral cancer   Malignant transformation   Survival oral cancer   Treatment oral cancer   Potentially malignant oral lesion   Recurrence oral cancer   Recurrence oral dysplasia   Laser oral cancer
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号